Iron Deficiency, Vitamin A Deficiency, Zinc Deficiency
Conditions
Keywords
iron, zinc, vitamin A, biofortified, efficacy, India, infant, trial
Brief summary
In this study, meals based on multiple food crops (containing either biofortified or commercially-available food crops) will be fed to young children in Madanapalle, Andhra Pradesh, India over a period of nine months to measure growth, cognitive changes, and immune function in comparison to children receiving non-biofortified crops. Mothers of the participating children will also be included in the study.
Detailed description
Iron, zinc, and vitamin A deficiency remain a major worldwide public health problem especially in developing countries such as India. In this randomized study, 200 children aged 6-12 months (and their lactating mothers) from Madanapalle, Andhra Pradesh, India will be fed meals based on (either biofortified or commercially-available) multiple food crops three times per day, six days per week, for nine months. We will recruit children from 6 - 24 months of age. The goal of this study is to examine the effects of the biofortified multiple food crops on immune function, growth, and cognitive function in this age group. The key outcome measures are biomarkers of vitamin A, iron and zinc status, growth (anthropometric z-scores), and immune and cognitive function. Nutrient biomarkers will be assessed at enrollment (baseline), at an intermediate time point (midline; random serial sampling) and after 9 months of follow-up (endline). Additionally, we will measure concentrations of C-reactive protein (CRP) and alpha 1-acid glycoprotein (AGP), as iron and zinc biomarkers can be influenced by inflammation. To assess cognitive function, multiple specific aspects of memory and attention will be assessed. Higher-level, integrative cognitive abilities that require the coordination of multiple specific functions, such as problem-solving and exploratory behavior and global aspects of attention during free play with toys, will also be assessed. In addition, the Development Assessment Scales for Indian Infants (DASII) test will be conducted at baseline, intermediate, and endline assessments to obtain a broad measure of attainment of developmental milestones that can be used to compare the characteristics of this cohort with those reported in the literature.
Interventions
OTHERMultiple biofortified food crops (MBFC-Exp)
Meals from three biofortified food crops will be consumed by children (and potentially their lactating mothers) three times per day, six days per week, for 9 months.
OTHERCommercially available non-fortified food crops (MBFC-C)
This arm will consume meals based on three commercially available (non-biofortified) food crops three times per day, six days per week, for 9 months.
Sponsors
SNDT Women's University
Arogyavaram Medical Centre
Cornell University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
DOUBLE (Subject, Investigator)
Eligibility
Sex/Gender
ALL
Age
6 Months to 24 Months
Healthy volunteers
No
Inclusion criteria
Children: Age 6 to 24 months (at enrollment); Mothers: Biological mothers of included children.
Exclusion criteria
Children * Age below 6 months or above 24 months (at time of screening); * Hemoglobin \<9 g/dL (at time of screening); * Presence of severe malnutrition according to Wellcome Classification (marasmus, marasmic kwashiorkor, kwashiorkor, weight-for-height z-score \< -3); * Prior known or current diagnoses of HIV/AIDS, Malaria, Dengue fever, Tuberculosis; * Children whose biological mother is unable to bring her/him to feeding center daily; * Possibility of migrating out of the study catchment area for more than 4 consecutive weeks; * Prior or current consumption of iron, zinc, and/or vitamin A supplements; * Any known dietary allergies. Mothers \- Severe anemia (Hemoglobin \<7g/ dL)
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Biomarkers of vitamin A, iron, and zinc status | endline (9 months) | Determined by serum ferritin (ng/mL) after nine months' intervention. |
| Physical growth | endline (9 months) | As determined by length/height (cm) after nine months' intervention. |
| Immune function | endline (9 months) | As assessed by cytokines and vaccine response after 9 months of intervention. |
Countries
India
Outcome results
None listed